Using the median expression levels of GITR or GITRL as a cut-off, GITR trended towards a correlation with OS in CLL, indicating a prognostic role in CLL as reported for platelet derived GITR in breast cancer [42]. The gene discussed is TNFSF18; the disease is B-cell chronic lymphocytic leukemia.